Zusammenfassung
Das Wachstum stellt einen Schwerpunkt der alltäglichen pädiatrischen Praxis dar. Der häufigste Vorstellungsgrund in einer endokrinologischen Sprechstunde ist der Kleinwuchs. Etwa 75% dieser Patienten zeigen eine somatische Entwicklungsverzögerung, welche hauptsächlich konstitutionell (genetisch) bedingt ist. Diese Patientengruppe ist relativ leicht durch anamnestische, klinische und radiologische Kriterien von anderen schwierigeren endokrinologischen und nichtendokrinologischen Kleinwuchsformen zu differenzieren.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Albertsson-Wiklang K, Aronson AS, Gustafsson J et al. (2008) Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency. J Clin Endocrin Metab 93: 4342–4350
Chatelain P, Carracosa A, Bona G, Ferrandez-Longas A, Sippell W (2007) Growth hormone therapy for short children bron small for gestation age. Horm Res 68: 300–309
Chatelain P, Zegher F de (1999) Growth hormone treatment in children with intrauterine growth retardation and Silver-Russell syndrome. In: Ranke MB, Wilton P (eds) Growth hormone therapy in KIGS – 10 years’ experience. Barth, Mannheim, pp 305–319
Cohen P, Rogol AD, Deal CL et al. (2008) 2007 Consensus Workshop participants: consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pedoatric Endocrine Society and the European Society of Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 93: 4210–4217
Cuttler L (2005) Editorial: safety and efficacy of growth hormone treatment for idiopathic short stature. J Clin Endocrinol Metab 90: 5502–5504
Dahlgren J, Wikland KA; Swedish Study Group for Growth Hormone Treatment (2005) Final height in short children born small for gestational age treated with GH. Pediatr Res 57: 216–222
Darendeliler F, Ranke MB, Bakker B et al. (2005) Bone age progression during the first year of growth hormone therapy in prepubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database). Horm Res 63: 40–47
de Zegher F, Hokken-Koelega A (2005) Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term. Pediatrics 115: e458–462
Hintz RL, Attie KM, Baptista J, Roche A (1999) Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech collaborative group. N Engl J Med 340: 502–507
Ong K, Beardsall K, de Zegher F (2005) Growth hormone therapy in short children born small for gestational age. Early Hum Dev 81: 973–980
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schmidt, H. (2014). Kleinwuchs. In: Reinhardt, D., Nicolai, T., Zimmer, KP. (eds) Therapie der Krankheiten im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41814-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-41814-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41813-6
Online ISBN: 978-3-642-41814-3
eBook Packages: Medicine (German Language)